title: Monoamine oxidase inhibitors potentiate the effects of deep brain stimulation.
authors.forename: Clement
authors.initials: C
authors.lastname: Hamani
authors.forename: Peter
authors.initials: P
authors.lastname: Giacobbe
authors.forename: Mustansir
authors.initials: M
authors.lastname: Diwan
authors.forename: Eliane S
authors.initials: ES
authors.lastname: Balbino
authors.forename: Junchao
authors.initials: J
authors.lastname: Tong
authors.forename: Alanna
authors.initials: A
authors.lastname: Bridgman
authors.forename: Nir
authors.initials: N
authors.lastname: Lipsman
authors.forename: Andres M
authors.initials: AM
authors.lastname: Lozano
authors.forename: Sidney H
authors.initials: SH
authors.lastname: Kennedy
authors.forename: José N
authors.initials: JN
authors.lastname: Nobrega
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D046690:Deep Brain Stimulation / Q000379:methods*; D003866:Depressive Disorder / Q000628:therapy*; D006801:Humans; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D014191:Tranylcypromine / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine